Article Details

BridgeBio Pharma, Inc. Reports Third Quarter 2022 Financial Results and Business Update

Retrieved on: 2022-11-03 18:35:12

Tags for this article:

Click the tags to see associated articles and topics

BridgeBio Pharma, Inc. Reports Third Quarter 2022 Financial Results and Business Update. View article details on hiswai:

Excerpt

Cash, cash equivalents and marketable securities, excluding restricted cash, totaled $558.3 ... Investment in equity securities, 33,662, 49,148.

Article found on: www.einnews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up